Dr. Iván Sanz-Muñoz, National Influenza Centre, Valladolid, Calle Rondilla de Santa Teresa s/n, Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Rev Esp Quimioter. 2024 Jun;37(3):209-220. doi: 10.37201/req/006.2024. Epub 2024 Mar 21.
The properties of the main surface proteins and the viral cycle of the respiratory syncytial virus (RSV) make it an attractive pathogen from the perspective of microbiology. The virus gets its name from the manner it infects cells, which enables it to produce syncytia, which allow the virus' genetic material to move across cells without having to release viral offspring to the cellular exterior, reducing immune system identification. This causes a disease with a high impact in both children and adults over 60, which has sparked the development of several preventive interventions based on vaccines and monoclonal antibodies for both age groups. The epidemiological characteristics of this virus, which circulates in epidemics throughout the coldest months of the year and exhibits a marked genetic and antigenic drift due to its high mutation capability, must be taken into consideration while using these preventive methods. The most important microbiological and epidemiological elements of RSV are covered in this study, along with how they have affected the creation of preventive medications and their use in the future.
呼吸道合胞病毒（RSV）的主要表面蛋白特性和病毒周期使其成为微生物学中具有吸引力的病原体。该病毒因其感染细胞的方式而得名，这种方式使其能够产生合胞体，从而使病毒的遗传物质能够在不将病毒后代释放到细胞外的情况下在细胞间移动，从而降低免疫系统的识别能力。这导致了一种在儿童和 60 岁以上成年人中都有很高影响的疾病，这促使针对这两个年龄段的疫苗和单克隆抗体的几种预防干预措施的发展。在使用这些预防方法时，必须考虑到这种病毒的流行病学特征，即它在一年中最冷的几个月流行，并由于其高突变能力而表现出明显的遗传和抗原漂移。本研究涵盖了 RSV 的最重要的微生物学和流行病学因素，以及它们如何影响预防药物的研发及其在未来的应用。
